Evidence-Based Complementary and Alternative Medicine

Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes


Publishing date
05 Jul 2013
Status
Published
Submission deadline
15 Feb 2013

1National Brain Research Centre, Manesar, Gurgaon 122 050, India

2Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA


Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes

Description

Modernization of life style and dietary habits has given birth to enemies of mankind such as obesity, metabolic syndrome, and type II diabetes. These modern-day diseases are taking epidemic proportion across the globe affecting both developed as well as developing countries. Taken together, these diseases claim the highest number of deaths worldwide leaving behind cancer. Although various synthetic drugs are available for treatment of hyperlipidemia/hypercholesterolemia and related disorders such as obesity, steatohepatitis, and atherosclerosis, ironically manifestation of side effects greatly limited their usage. Further, synthetic antidiabetic and hypolipidemic drugs are also unable to alleviate the pleiotropic effects of these metabolic disorders. On the other hand, herbal medicines are gaining increasing popularity and recognition in the management of obesity, metabolic syndrome, and type II diabetes because of their minimal side effects. Thus, herbal medicines represent future hope for the pharmacological management of these diseases due to their multicomponent, multitarget actions.

We invite investigators to submit original research and review articles on preclinical and clinical evaluation of natural products as therapy for diabetes, obesity, and metabolic syndrome. The topic would include medicinal plants, natural products, and herbal medicine in Asia, Ayurvedic, and other countries. Potential topics include, but are not limited to:

  • Studies on antidiabetic and antiobesity potential of herbal extracts/compounds using in vitro and in vivo experimental models
  • Clinical trials/reports on the efficacy of medicinal plants/natural products for the prevention/treatment of obesity, metabolic syndrome, and type II diabetes
  • Natural products for diabetic complications and nonalcoholic fatty liver disease
  • Role of natural products in ameliorating oxidative stress and inflammatory conditions associated with obesity, metabolic syndrome, and type II diabetes
  • Safety evaluation of known antidiabetic and antiobesity plants/natural products

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ecam/omd/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2013
  • - Article ID 172537
  • - Research Article

Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model

Despina Harbilas | Diane Vallerand | ... | Pierre S. Haddad
  • Special Issue
  • - Volume 2013
  • - Article ID 185259
  • - Research Article

Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet

G. Kanagasabapathy | S. N. A. Malek | ... | U. R. Kuppusamy
  • Special Issue
  • - Volume 2013
  • - Article ID 212139
  • - Research Article

Combined Ethanol Extract of Grape Pomace and Omija Fruit Ameliorates Adipogenesis, Hepatic Steatosis, and Inflammation in Diet-Induced Obese Mice

Su-Jung Cho | Un Ju Jung | ... | Myung-Sook Choi
  • Special Issue
  • - Volume 2013
  • - Article ID 261468
  • - Research Article

Pharmacometrics of 3-Methoxypterostilbene: A Component of Traditional Chinese Medicinal Plants

Stephanie E. Martinez | Casey L. Sayre | Neal M. Davies
  • Special Issue
  • - Volume 2013
  • - Article ID 943075
  • - Review Article

Significance of Kampo, Japanese Traditional Medicine, in the Treatment of Obesity: Basic and Clinical Evidence

Jun-ichi Yamakawa | Junji Moriya | ... | Junji Kobayashi
  • Special Issue
  • - Volume 2013
  • - Article ID 867893
  • - Research Article

Boehmeria nivea Stimulates Glucose Uptake by Activating Peroxisome Proliferator-Activated Receptor Gamma in C2C12 Cells and Improves Glucose Intolerance in Mice Fed a High-Fat Diet

Sung Hee Kim | Mi Jeong Sung | ... | Jin-Taek Hwang
  • Special Issue
  • - Volume 2013
  • - Article ID 549345
  • - Research Article

In Vitro Evaluations of Cytotoxicity of Eight Antidiabetic Medicinal Plants and Their Effect on GLUT4 Translocation

Sleman Kadan | Bashar Saad | ... | Hilal Zaid
  • Special Issue
  • - Volume 2013
  • - Article ID 285489
  • - Research Article

Effect of Berberine on PPARα/NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy

Mingfeng Wang | Jia Wang | ... | Qingsong Jiang
  • Special Issue
  • - Volume 2013
  • - Article ID 756025
  • - Research Article

The Extract of Herbal Medicines Activates AMP-Activated Protein Kinase in Diet-Induced Obese Rats

Hye-Yeon Shin | SaeYeon Chung | ... | Seong-Gyu Ko
  • Special Issue
  • - Volume 2013
  • - Article ID 303902
  • - Research Article

Quercetin Preserves β-Cell Mass and Function in Fructose-Induced Hyperinsulinemia through Modulating Pancreatic Akt/FoxO1 Activation

Jian-Mei Li | Wei Wang | ... | Ling-Dong Kong
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision68 days
Acceptance to publication33 days
CiteScore2.900
Impact Factor1.813
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.